Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies.
about
SR calcium handling dysfunction, stress-response signaling pathways, and atrial fibrillation.Effects of metoprolol therapy on cardiac gap junction remodelling and conduction in human chronic atrial fibrillation.Is there a role for remodeled connexins in AF? No simple answers.Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.Pharmacological modulation of gap junction function with the novel compound rotigaptide: a promising new principle for prevention of arrhythmias.Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation.Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins.Atrial remodeling in atrial fibrillation and some related microRNAs.Novel molecular targets for atrial fibrillation therapy.Connexins in the heart.Connexin gene transfer preserves conduction velocity and prevents atrial fibrillation.Limited Ablation for Persistent Atrial Fibrillation Using Preprocedure Reverse Remodelling.Connexin Remodeling Contributes to Atrial Fibrillation.The Stress-Response MAP Kinase Signaling in Cardiac Arrhythmias.Atrial Remodeling And Atrial Fibrillation: Mechanistic Interactions And Clinical Implications.Functional characterization of atrial electrograms in a pacing-induced heart failure model of atrial fibrillation: importance of regional atrial connexin40 remodeling.Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.Reduced connexin40 protein expression in the right atrial appendage of patients bearing the minor connexin40 allele (-44 G --> A).Activin Receptor-Like Kinase 4 Haplodeficiency Mitigates Arrhythmogenic Atrial Remodeling and Vulnerability to Atrial Fibrillation in Cardiac Pathological Hypertrophy
P2860
Q35099320-C01FD9B0-3047-41CA-B76C-256D184DA0FDQ35287322-C8356E08-3A37-4A78-BCD8-73D986BA768AQ36459867-9451A9CD-38B4-42CE-A555-D8C0D691A7D0Q36788875-3F16E8A5-3DE6-47F0-8A1E-2292DA35088AQ36936412-7E4188CA-B5F7-41D0-ABA8-E9952B7CEDF6Q37496128-79372CC3-8EB2-4699-99A9-A70B40B1659CQ37602866-6C2A0E73-AED6-47EF-A228-B7F1F86B18BBQ37969565-799A4A78-CD7B-4B70-B1A5-259E49B846D7Q37998312-46021F11-CC31-40D9-863A-3649A3C7C07CQ38263987-D9737CD3-4C2A-45D4-A5FE-67260BFF3994Q38435600-9B960ABC-E9FB-426F-9318-839F846323DFQ38719275-56E30580-17C6-4971-A895-951E424CA3D6Q38790389-77E1F9B2-D3D8-4965-A856-67352C116814Q38795069-32E173F6-A6B4-45FA-91A4-2F5DD105CA24Q39300430-4785FEA7-F834-4E56-8513-552F04EE6B9CQ46011913-D8433243-2834-440D-BA75-EE7E8BDBB23DQ47770967-250D4C92-462E-41FE-8D70-48E6404A81D6Q54318904-E446C7A5-3D51-4D88-BF33-96DB4BF58A60Q58129769-FCA54921-4EF7-4C34-AB87-6883E8B3062A
P2860
Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Expression of connexins 40 and ...... tion of different aetiologies.
@en
Expression of connexins 40 and ...... tion of different aetiologies.
@nl
type
label
Expression of connexins 40 and ...... tion of different aetiologies.
@en
Expression of connexins 40 and ...... tion of different aetiologies.
@nl
prefLabel
Expression of connexins 40 and ...... tion of different aetiologies.
@en
Expression of connexins 40 and ...... tion of different aetiologies.
@nl
P2093
P2860
P356
P1433
P1476
Expression of connexins 40 and ...... tion of different aetiologies.
@en
P2093
A Dorszewski
G Hindricks
H Kottkamp
J Lauschke
P Schirdewahn
P2860
P304
P356
10.1136/HRT.2003.024216
P407
P577
2005-02-01T00:00:00Z